ELLINGTON MANAGEMENT GROUP LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 110 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$223,000
-70.6%
3,300
-83.6%
0.02%
-92.3%
Q3 2016$759,000
+246.6%
20,100
+62.1%
0.21%
+287.0%
Q2 2015$219,00012,4000.05%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 244,783$1,718,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$32,959,0000.69%
DCF Advisers, LLC 192,065$1,348,0000.55%
LEVIN CAPITAL STRATEGIES, L.P. 817,377$5,738,0000.54%
DAFNA Capital Management LLC 289,040$2,029,0000.51%
Rhenman & Partners Asset Management AB 750,000$5,378,0000.36%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,175,0000.31%
RICE HALL JAMES & ASSOCIATES, LLC 1,203,592$8,449,0000.30%
AlphaCentric Advisors LLC 137,000$962,0000.28%
PFM Health Sciences, LP 1,088,566$7,642,0000.26%
View complete list of AERIE PHARMACEUTICALS INC shareholders